PL3522874T3 - Kompozycje zawierające hydroksytyrozol i kwas bosweliowy - Google Patents

Kompozycje zawierające hydroksytyrozol i kwas bosweliowy

Info

Publication number
PL3522874T3
PL3522874T3 PL17720995.4T PL17720995T PL3522874T3 PL 3522874 T3 PL3522874 T3 PL 3522874T3 PL 17720995 T PL17720995 T PL 17720995T PL 3522874 T3 PL3522874 T3 PL 3522874T3
Authority
PL
Poland
Prior art keywords
hydroxytyrosol
compositions
boswellic acid
boswellic
acid
Prior art date
Application number
PL17720995.4T
Other languages
English (en)
Polish (pl)
Inventor
Todd Henderson
David Griffin
Original Assignee
Nutramax Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories, Inc. filed Critical Nutramax Laboratories, Inc.
Publication of PL3522874T3 publication Critical patent/PL3522874T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
PL17720995.4T 2016-10-04 2017-04-21 Kompozycje zawierające hydroksytyrozol i kwas bosweliowy PL3522874T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662403807P 2016-10-04 2016-10-04
PCT/US2017/028857 WO2018067200A1 (en) 2016-10-04 2017-04-21 Compositions comprising hydroxytyrosol and boswellic acid

Publications (1)

Publication Number Publication Date
PL3522874T3 true PL3522874T3 (pl) 2025-10-06

Family

ID=58664857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17720995.4T PL3522874T3 (pl) 2016-10-04 2017-04-21 Kompozycje zawierające hydroksytyrozol i kwas bosweliowy

Country Status (9)

Country Link
US (5) US10342802B2 (enExample)
EP (2) EP4623994A3 (enExample)
JP (5) JP7079551B2 (enExample)
CN (2) CN120241745A (enExample)
AU (3) AU2017340126B2 (enExample)
CA (1) CA3039233A1 (enExample)
ES (1) ES3040765T3 (enExample)
PL (1) PL3522874T3 (enExample)
WO (1) WO2018067200A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3039233A1 (en) 2016-10-04 2018-04-12 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
CN115282154A (zh) * 2022-08-15 2022-11-04 武汉科前生物股份有限公司 11-羰基-β-乙酰乳香酸在制备治疗猫传腹药物中的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358542B2 (en) 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
US7713569B2 (en) 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
JP3820218B2 (ja) 2000-09-01 2006-09-13 クレアグリ， インコーポレイテッド 植物水からヒドロキシチロソール富化組成物を得る方法
WO2003068171A2 (en) 2002-02-13 2003-08-21 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
WO2003077860A2 (en) * 2002-03-13 2003-09-25 Biophysica, Inc. BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES
EP1582512A1 (en) 2004-03-31 2005-10-05 Cognis IP Management GmbH Process for obtaining hydroxytyrosol from olive leaves extracts
US7625947B2 (en) 2004-06-18 2009-12-01 Laila Nutraceuticals Analogs of 3-O-acetyl-11-keto-β-boswellic acid
JP2008509224A (ja) * 2004-08-09 2008-03-27 クレアグリ， インコーポレイテッド 炎症状態を治療するためのオリーブ組成物及び方法
CN101516364B (zh) * 2006-07-14 2011-12-28 帝斯曼知识产权资产管理有限公司 组合物及其用于治疗、共治疗或预防炎性病症的用途
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
JP2008120716A (ja) 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
WO2010029578A2 (en) 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
CN102451428A (zh) * 2010-10-14 2012-05-16 中国中医科学院广安门医院 可用于治疗类风湿关节炎的中药组合物
US9144555B2 (en) * 2012-11-30 2015-09-29 Darlene E. McCord Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
CA3039233A1 (en) 2016-10-04 2018-04-12 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid

Also Published As

Publication number Publication date
EP4623994A2 (en) 2025-10-01
JP2026127783A (ja) 2026-08-06
JP7876938B2 (ja) 2026-06-22
CN120241745A (zh) 2025-07-04
JP2022110125A (ja) 2022-07-28
JP7341596B2 (ja) 2023-09-11
EP4623994A3 (en) 2025-11-19
CA3039233A1 (en) 2018-04-12
JP7562225B2 (ja) 2024-10-07
WO2018067200A1 (en) 2018-04-12
JP7079551B2 (ja) 2022-06-02
JP2024166415A (ja) 2024-11-28
AU2017340126B2 (en) 2023-03-02
US10722524B2 (en) 2020-07-28
US20240285648A1 (en) 2024-08-29
JP2019529482A (ja) 2019-10-17
US10342802B2 (en) 2019-07-09
US20200222424A1 (en) 2020-07-16
US11980624B2 (en) 2024-05-14
EP3522874A1 (en) 2019-08-14
US11241444B2 (en) 2022-02-08
ES3040765T3 (en) 2025-11-04
AU2025202875B2 (en) 2026-07-09
US20220110946A1 (en) 2022-04-14
AU2017340126A1 (en) 2019-04-11
AU2023203427B2 (en) 2025-02-06
AU2023203427A1 (en) 2023-06-29
US20180092928A1 (en) 2018-04-05
CN109789110A (zh) 2019-05-21
AU2025202875A1 (en) 2025-05-15
JP2023159387A (ja) 2023-10-31
EP3522874B1 (en) 2025-07-02
US20190231796A1 (en) 2019-08-01

Similar Documents

Publication Publication Date Title
PL3355990T3 (pl) Semifluorowane związki oraz ich kompozycje
GB201513304D0 (en) Compositions and Methods
SG11201608217PA (en) Fatty acid composition and use thereof
ZA201708004B (en) Ether compounds and related compositions
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
GB201619962D0 (en) Synthetic acid compositions and uses thereof
GB201502002D0 (en) Uses and compositions
GB201506526D0 (en) Medicinal composition
SG11201803026RA (en) Compositions comprising choline and their use
PT3316856T (pt) Formulações misturadas
GB201608762D0 (en) Compositions and uses thereof
HUE044889T2 (hu) Gyógyászati készítmények
IL257806A (en) Laxative formulations and manufacture
SI3474858T1 (sl) Dvokomponentni sestavek, ki obsega acetilsalicilno kislino
IL249695A0 (en) Converted polymyxins and preparations containing them
LT3302483T (lt) Farmacinės kompozicijos ir jų panaudojimas
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
GB201512996D0 (en) Compositions and methods
PL3313369T3 (pl) Kompozycja emolientu
GB201614897D0 (en) Compositions and uses thereof
GB201511886D0 (en) Uses and compositions
GB201522814D0 (en) Compositions and uses thereof
GB201602409D0 (en) Compositions and uses thereof
HUE057047T2 (hu) Turmeronokat tartalmazó bõrkezelõ készítmények